Evelo Biosciences (EVLO) Short Interest Ratio & Short Volume $0.0005 0.00 (0.00%) As of 08/21/2025 03:20 PM Eastern Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsInsider TradesSEC FilingsShort InterestTrendsBuy This Stock Evelo Biosciences Short Interest DataEvelo Biosciences (EVLO) has a short interest of 6,700 shares, representing 0.04% of the float (the number of shares available for trading by the public). This marks a 0.00% change in short interest from the previous month. The short interest ratio (days to cover) is 3.7, indicating that it would take 3.7 days of the average trading volume of 10,117 shares to cover all short positions.Current Short Interest6,700 sharesPrevious Short Interest6,700 sharesChange Vs. Previous MonthNo ChangeDollar Volume Sold Short$3.35Short Interest Ratio3.7 Days to CoverLast Record DateJuly 31, 2025Outstanding Shares18,983,000 sharesShort Percent of Float0.04%Today's Trading Volume615 sharesAverage Trading Volume10,117 sharesToday's Volume Vs. Average6% Short Selling Evelo Biosciences? Sign up to receive the latest short interest report for Evelo Biosciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartEVLO Short Interest Over TimeEVLO Days to Cover Over TimeEVLO Percentage of Float Shorted Over Time Evelo Biosciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/31/20256,700 shares $3.35 No Change0.0%3.7 $0.00 7/15/20256,700 shares $3.35 No ChangeN/A8.4 $0.00 6/30/20256,700 shares $3.35 No Change0.0%9.6 $0.00 6/15/20256,700 shares $3.35 No Change0.0%0.3 $0.00 5/31/20256,700 shares $2.68 No Change0.0%1 $0.00 5/15/20256,700 shares $2.01 No ChangeN/A4.2 $0.00 4/30/20256,700 shares $3.35 No ChangeN/A33.5 $0.00 4/15/20256,700 shares $3.35 No ChangeN/A6.1 $0.00 3/14/20256,700 shares $3.35 No ChangeN/A16.8 $0.00 2/28/20256,700 shares $16.75 No ChangeN/A67 $0.00 Get the Latest News and Ratings for EVLO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Evelo Biosciences and its competitors with MarketBeat's FREE daily newsletter. 2/14/20256,700 shares $3.35 -1.5%N/A2.2 $0.00 1/31/20256,800 shares $3.40 No ChangeN/A0.2 $0.00 1/15/20256,800 shares $3.40 No ChangeN/A8.5 $0.00 11/30/2023197,000 shares $78.82 thousand -54.2%2.1%0.3 $0.40 11/15/2023430,100 shares $191.48 thousand +175.0%4.6%0.6 $0.45 10/31/2023156,400 shares $64.28 thousand -76.6%1.7%0.4 $0.41 10/15/2023667,800 shares $2.08 million +13.9%7.2%2.6 $3.12 9/30/2023586,400 shares $2.30 million +119.1%6.3%1.1 $3.92 9/15/2023267,700 shares $1.36 million -3.8%2.9%0.4 $5.07 8/31/2023278,200 shares $1.84 million -10.8%3.0%0.3 $6.61 8/15/2023312,000 shares $4.15 million -31.7%3.4%0.4 $13.31 7/31/2023456,600 shares $4.78 million +123.0%4.9%0.6 $10.47 7/15/2023204,800 shares $739.33 thousand -47.3%2.2%0.2 $3.61 6/30/2023388,300 shares $25.24 million -78.4%13.9%0.7 $65.00 6/15/20231,800,000 shares $149.22 thousand -41.6%N/A0.2 $0.08 5/31/20233,080,000 shares $420.42 thousand -13.7%N/A0.8 $0.14 5/15/20233,570,000 shares $505.51 thousand +58.7%N/A1 $0.14 4/30/20232,250,000 shares $346.05 thousand -10.0%N/A0.6 $0.15 4/15/20232,500,000 shares $418.25 thousand -15.8%N/A7.6 $0.17 3/31/20232,970,000 shares $536.68 thousand +3.9%N/A10.6 $0.18 3/15/20232,860,000 shares $900.90 thousand +4.4%N/A18.1 $0.32 2/28/20232,740,000 shares $1.70 million -22.2%N/A20.7 $0.62 2/15/20233,520,000 shares $2.83 million -21.4%N/A26.5 $0.81 1/31/20234,480,000 shares $4.66 million No ChangeN/A33.8 $1.04 1/15/20234,480,000 shares $6.18 million +2.5%N/A38.5 $1.38 12/30/20224,370,000 shares $7.04 million -1.8%N/A41 $1.61 12/15/20224,450,000 shares $8.23 million +0.5%N/A44.3 $1.85 11/30/20224,430,000 shares $9.26 million -0.7%N/A29 $2.09 11/15/20224,460,000 shares $9.77 million +0.2%8.5%28.6 $2.19 10/31/20224,450,000 shares $9.08 million No ChangeN/A30.6 $2.04Everyone’s watching Nvidia right now. Here’s why I’m excited. (Ad)So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal with Saudi Arabia to power its new AI empire 🤯 We’re talking about hundreds of thousands of chips, including their latest Grace Blackwell supercomputer.🎯 Click here to watch the video and get the free ticker XGPT just flagged. 10/15/20224,450,000 shares $9.57 million -2.2%N/A34.1 $2.15 9/30/20224,550,000 shares $9.51 million +13.2%N/A32.5 $2.09 9/15/20224,020,000 shares $8.52 million -1.0%N/A18.8 $2.12 8/31/20224,060,000 shares $8.89 million +2.0%N/A18.9 $2.19 8/15/20223,980,000 shares $10.95 million -3.6%N/A14.9 $2.75 7/31/20224,130,000 shares $8.71 million -1.2%N/A14 $2.11 7/15/20224,180,000 shares $9.20 million -4.1%N/A12.2 $2.20 6/30/20224,360,000 shares $9.20 million -23.9%N/A11.9 $2.11 6/15/20225,730,000 shares $10.43 million -22.5%N/A14.5 $1.82 5/31/20227,390,000 shares $15.52 million -8.1%N/A23.3 $2.10 5/15/20228,040,000 shares $13.27 million -4.2%29.5%26.3 $1.65 4/30/20228,390,000 shares $20.72 million -0.5%30.8%25.1 $2.47 4/15/20228,430,000 shares $21.41 million No Change31.5%25.2 $2.54 3/31/20228,430,000 shares $28.58 million +2.6%N/A0 $3.39 3/15/20228,220,000 shares $23.43 million +0.6%30.9%27.2 $2.85 2/28/20228,170,000 shares $25.57 million +10.0%30.7%28.3 $3.13 2/15/20227,430,000 shares $29.94 million +11.9%27.9%27.2 $4.03 1/31/20226,640,000 shares $31.27 million +6.8%25.0%28.8 $4.71 1/15/20226,220,000 shares $34.33 million +5.4%N/A24.6 $5.52 12/31/20215,900,000 shares $35.81 million +7.3%22.2%20.9 $6.07 12/15/20215,500,000 shares $42.68 million +6.6%20.7%15.5 $7.76 11/30/20215,160,000 shares $44.48 million -5.3%19.4%13.8 $8.62 11/15/20215,450,000 shares $55.97 million +4.2%20.5%14.5 $10.27 10/29/20215,230,000 shares $46.29 million -3.3%19.7%14.5 $8.85 10/15/20215,410,000 shares $43.01 million +11.8%20.4%17.2 $7.95 9/30/20214,840,000 shares $34.07 million +35.2%18.2%15.6 $7.04 9/15/20213,580,000 shares $25.02 million +12.2%13.5%15.7 $6.99 8/31/20213,190,000 shares $36.27 million -1.5%12.0%17.7 $11.37 8/13/20213,240,000 shares $33.66 million -10.5%12.2%18.2 $10.39 7/30/20213,620,000 shares $33.34 million +10.4%13.6%19.8 $9.21 7/15/20213,280,000 shares $36.08 million +19.7%12.4%17.6 $11.00 6/30/20212,740,000 shares $37.65 million +7.9%10.3%13.1 $13.74 6/15/20212,540,000 shares $41.53 million -2.7%9.6%14.1 $16.35 5/28/20212,610,000 shares $35.03 million -13.3%9.8%12.8 $13.42 5/14/20213,010,000 shares $33.14 million +13.6%11.3%13.4 $11.01 4/30/20212,650,000 shares $32.44 million +1.5%9.0%11.3 $12.24 4/15/20212,610,000 shares $29.10 million -17.9%N/A0 $11.15 3/31/20213,180,000 shares $32.98 million +8.2%12.2%11.5 $10.37 3/15/20212,940,000 shares $35.13 million +25.6%11.3%9.6 $11.95 2/26/20212,340,000 shares $31.94 million -11.0%10.3%5.6 $13.65 2/12/20212,630,000 shares $42.79 million +22.9%11.6%6.7 $16.27 1/29/20212,140,000 shares $39.80 million -14.1%9.4%5.5 $18.60 1/15/20212,490,000 shares $34.31 million +18.6%12.8%7.4 $13.78 12/31/20202,100,000 shares $25.33 million +5.0%14.2%6.3 $12.06 12/15/20202,000,000 shares $18.82 million -3.4%13.5%6.8 $9.41 11/30/20202,070,000 shares $10.76 million -0.5%14.0%14.1 $5.20 11/15/20202,080,000 shares $9.44 million +1.5%14.1%14 $4.54 10/30/20202,050,000 shares $8.90 million +7.3%13.9%13.7 $4.34 10/15/20201,910,000 shares $10.16 million +10.4%12.9%11.7 $5.32 9/30/20201,730,000 shares $9.12 million +19.3%11.7%11.1 $5.27Everyone’s watching Nvidia right now. Here’s why I’m excited. (Ad)So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal with Saudi Arabia to power its new AI empire 🤯 We’re talking about hundreds of thousands of chips, including their latest Grace Blackwell supercomputer.🎯 Click here to watch the video and get the free ticker XGPT just flagged. 9/15/20201,450,000 shares $7.66 million +5.1%9.8%8.2 $5.28 8/31/20201,380,000 shares $6.13 million +16.0%9.3%8.2 $4.44 EVLO Short Interest - Frequently Asked Questions What is Evelo Biosciences' current short interest? Short interest is the volume of Evelo Biosciences shares that have been sold short but have not yet been covered or closed out. As of July 31st, traders have sold 6,700 shares of EVLO short. 0.04% of Evelo Biosciences' shares are currently sold short. Learn More on Evelo Biosciences' current short interest. What is a good short interest ratio for Evelo Biosciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. EVLO shares currently have a short interest ratio of 4.0. Learn More on Evelo Biosciences's short interest ratio. What is a good short interest percentage for Evelo Biosciences? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.04% of Evelo Biosciences' floating shares are currently sold short. How does Evelo Biosciences' short interest compare to its competitors? 0.04% of Evelo Biosciences' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Evelo Biosciences: Syros Pharmaceuticals, Inc. (0.31%), Virpax Pharmaceuticals, Inc. (0.25%), Scopus BioPharma Inc. (0.03%), Comera Life Sciences Holdings, Inc. (0.02%), Genocea Biosciences, Inc. (0.33%), Aridis Pharmaceuticals, Inc. (0.05%), Calithera Biosciences, Inc. (0.15%), Statera Biopharma, Inc. (0.15%), Ampio Pharmaceuticals, Inc. (0.01%), PaxMedica, Inc. (0.01%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($70.87 billion), Invesco QQQ ($30.12 billion), iShares Russell 2000 ETF ($19.85 billion), iShares 20+ Year Treasury Bond ETF ($10.34 billion), Strategy Inc ($8.98 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($7.61 billion), SPDR S&P Biotech ETF ($6.81 billion), Invesco S&P 500 Equal Weight ETF ($6.14 billion), Palo Alto Networks, Inc. ($5.97 billion), and Super Micro Computer, Inc. ($5.28 billion). View all of the most shorted stocks. What does it mean to sell short Evelo Biosciences stock? Short selling EVLO is an investing strategy that aims to generate trading profit from Evelo Biosciences as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Evelo Biosciences? A short squeeze for Evelo Biosciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of EVLO, which in turn drives the price of the stock up even further. How often is Evelo Biosciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including EVLO, twice per month. The most recent reporting period available is July, 31 2025. More Short Interest Resources from MarketBeat Related Companies Syros Pharmaceuticals Short Interest Virpax Pharmaceuticals Short Interest Scopus BioPharma Short Interest Comera Life Sciences Short Interest Genocea Biosciences Short Interest Aridis Pharmaceuticals Short Interest Calithera Biosciences Short Interest Statera Biopharma Short Interest Ampio Pharmaceuticals Short Interest PaxMedica Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:EVLO) was last updated on 8/22/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTax Drain Deadline: Protect Your Wealth Before September 15thOn September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredThe stealth altcoin the financial world is underestimatingThis DeFi project could soar next When altcoin season fully kicks in—which the data suggests is happening R...Crypto 101 Media | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredA grave, grave error.Nvidia just shattered records—hitting $4 trillion in valuation faster than any company in history. But one ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evelo Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Evelo Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access